Analysis of Telephone Counseling of Patients in Chemotherapy Using Text Mining Technique

Purpose@#The purpose of this study was to analyze the frequency and relevance of frequent keywords using text mining analysis for symptom-related telephone counseling of patients undergoing chemotherapy, and to understand the current status and characteristics of the nursing intervention. @*Methods@#442 cases of telephone counseling of patients undergoing chemotherapy were collected. The symptoms were classified and separated according to the contents of the consultation between the nurse and the counseling participants. Using the python library, frequency words were extracted, and the generation of word co-occurrence matrices was analyzed through social network analysis. @*Results@#For the four cancers to be analyzed (breast, colorectum, stomach, lung), the common frequent words of nurse and counseling participants were ‘medical staff (uilyojin)’, ‘medical treatment (jinlyo)’, ‘treatment (chilyo)’, ‘other hospital (tabyeongwon)’, ‘prescription (cheobang)’. In the analysis of social networks, words with highly betweenness centrality, which appear in common, almost matched those of frequent words. @*Conclusion@#In this study, it was possible to extract the most frequent words by cancer type from the contents of telephone counseling with cancer patients and to understand the current status and context of the actual telephone counseling focusing on each keyword.

Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/ hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects

For the treatment of hypertension, fixed-dose combinations (FDCs) of antihypertensive drugs can provide complementary benefits from improved compliance and cost-effectiveness compared with loose combinations of corresponding drugs. A new FDC of fimasartan/ amlodipine/hydrochlorothiazide 60/10/25 mg is undergoing clinical development. A randomized, open-label, single-dose, 3-period, 3-sequence, partially replicated crossover phase 1 study was conducted to compare the pharmacokinetics (PKs) between the FDC of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a loose combination of a dual-combination FDC (fimasartan/amlodipine 60/10 mg) and hydrochlorothiazide 25 mg. Sixty healthy subjects were randomized, and 55 subjects completed the study. Serial blood samples were collected, and plasma concentrations of fimasartan, amlodipine and hydrochlorothiazide were measured to analyze PK parameters. The PK profiles of the FDC were similar to those of the loose combinations. The geometric mean ratios (GMRs) and 90% confidence intervals (CIs) of the FDC to loose combinations for the maximum plasma concentration (Cmax ) and area under the curve until the last measurable time point (AUClast ) were within the conventional bioequivalent range of 0.80 to 1.25. The GMRs and 90% CIs of fimasartan, amlodipine and hydrochlorothiazide were 1.0163 (0.8681–1.1898), 0.9595 (0.9256–0.9946), and 1.1294 (1.0791–1.1821) for Cmax and 1.0167 (0.9347–1.1059), 0.9575 (0.9317–0.9841), and 1.0561 (1.0170–1.0967) for AUClast , respectively. Both the FDC and loose combinations were well tolerated. In conclusion, the FDC of fimasartan/amlodipine/ hydrochlorothiazide 60/10/25 mg showed similar PK profiles to those of the corresponding loose combination, and both treatments were well tolerated.